Загрузка...
Systemic Immunotherapy for Urothelial Cancer: Current Trends and Future Directions
Urothelial cancer of the bladder, renal pelvis, ureter, and other urinary organs is the fifth most common cancer in the United States, and systemic platinum-based chemotherapy remains the standard of care for first-line treatment of advanced/metastatic urothelial carcinoma (UC). Until recently, ther...
Сохранить в:
| Опубликовано в: : | Cancers (Basel) |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5332938/ https://ncbi.nlm.nih.gov/pubmed/28134806 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers9020015 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|